Tofacitinib Ups Cancer, Cardiovascular Risks, FDA Warns
Agency to make recommendations after reviewing ORAL Surveillance results The FDA issued a Drug...
Product Alert
FDA Adds Risk of Abuse, Addiction to Boxed Warning for Benzodiazepines
Agency warns of potential for life-threatening withdrawal reactions WASHINGTON — The FDA is...
FDA Issues Guidance In Effort to Curb Surge in Nitrosamine Contamination
Agency calls on drug manufacturers to remain vigilant for NDMA, other impurities WASHINGTON...
The NDMA Nightmare Continues: FDA Warns of Metformin Contamination
Agency recommends voluntary recall of some extended release pills WASHINGTON —The FDA recommended that five manufacturers voluntarily recall several lots of the extended-release (ER) formulation of metformin after...
